Your browser doesn't support javascript.
loading
One-year pulmonary impairment after severe COVID-19: a prospective, multicenter follow-up study.
Faverio, Paola; Luppi, Fabrizio; Rebora, Paola; D'Andrea, Gabriele; Stainer, Anna; Busnelli, Sara; Catalano, Martina; Modafferi, Giuseppe; Franco, Giovanni; Monzani, Anna; Galimberti, Stefania; Scarpazza, Paolo; Oggionni, Elisa; Betti, Monia; Oggionni, Tiberio; De Giacomi, Federica; Bini, Francesco; Bodini, Bruno Dino; Parati, Mara; Bilucaglia, Luca; Ceruti, Paolo; Modina, Denise; Harari, Sergio; Caminati, Antonella; Intotero, Marcello; Sergio, Pietro; Monzillo, Giuseppe; Leati, Giovanni; Borghesi, Andrea; Zompatori, Maurizio; Corso, Rocco; Valsecchi, Maria Grazia; Bellani, Giacomo; Foti, Giuseppe; Pesci, Alberto.
Afiliación
  • Faverio P; Department of Medicine and Surgery, Università degli Studi di Milano Bicocca, Respiratory Unit, San Gerardo Hospital, ASST di Monza, via Pergolesi 33, 20900, Monza, Italy. paola.faverio@unimib.it.
  • Luppi F; Department of Medicine and Surgery, Università degli Studi di Milano Bicocca, Respiratory Unit, San Gerardo Hospital, ASST di Monza, via Pergolesi 33, 20900, Monza, Italy.
  • Rebora P; Bicocca Bioinformatics Biostatistics and Bioimaging B4 Center, University of Milano Bicocca, Monza, Italy.
  • D'Andrea G; Radiology Unit, Gerardo Hospital, ASST Monza, Monza, Italy.
  • Stainer A; Department of Medicine and Surgery, Università degli Studi di Milano Bicocca, Respiratory Unit, San Gerardo Hospital, ASST di Monza, via Pergolesi 33, 20900, Monza, Italy.
  • Busnelli S; Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, Pieve Emanuele, 20072, Milan, Italy.
  • Catalano M; IRCCS Humanitas Research Hospital, Respiratory Unit, Via Manzoni 56, 20089, Rozzano, Milan, Italy.
  • Modafferi G; Department of Medicine and Surgery, Università degli Studi di Milano Bicocca, Respiratory Unit, San Gerardo Hospital, ASST di Monza, via Pergolesi 33, 20900, Monza, Italy.
  • Franco G; Department of Medicine and Surgery, Università degli Studi di Milano Bicocca, Respiratory Unit, San Gerardo Hospital, ASST di Monza, via Pergolesi 33, 20900, Monza, Italy.
  • Monzani A; Department of Medicine and Surgery, Università degli Studi di Milano Bicocca, Respiratory Unit, San Gerardo Hospital, ASST di Monza, via Pergolesi 33, 20900, Monza, Italy.
  • Galimberti S; Department of Medicine and Surgery, Università degli Studi di Milano Bicocca, Respiratory Unit, San Gerardo Hospital, ASST di Monza, via Pergolesi 33, 20900, Monza, Italy.
  • Scarpazza P; Department of Medicine and Surgery, Università degli Studi di Milano Bicocca, Respiratory Unit, San Gerardo Hospital, ASST di Monza, via Pergolesi 33, 20900, Monza, Italy.
  • Oggionni E; Bicocca Bioinformatics Biostatistics and Bioimaging B4 Center, University of Milano Bicocca, Monza, Italy.
  • Betti M; Division of Pulmonary Medicine, Civile Hospital, Vimercate, MB, Italy.
  • Oggionni T; Division of Pulmonary Medicine, Civile Hospital, Vimercate, MB, Italy.
  • De Giacomi F; Division of Pulmonary Medicine, Cremona Hospital, ASST Cremona, Cremona, Italy.
  • Bini F; Division of Pulmonary Medicine, Cremona Hospital, ASST Cremona, Cremona, Italy.
  • Bodini BD; Division of Pulmonary Medicine, Cremona Hospital, ASST Cremona, Cremona, Italy.
  • Parati M; UOC Pulmonology, Department of Internal Medicine, Ospedale G. Salvini, ASST-Rhodense, Garbagnate Milanese, MI, Italy.
  • Bilucaglia L; UOC Pulmonology, Department of Internal Medicine, Ospedale G. Salvini, ASST-Rhodense, Garbagnate Milanese, MI, Italy.
  • Ceruti P; Department of Pulmonology and Respiratory High-Dependency Unit, Ospedale Maggiore, Crema, Italy.
  • Modina D; Department of Pulmonology and Respiratory High-Dependency Unit, Ospedale Maggiore, Crema, Italy.
  • Harari S; U.O. Pneumologia e Fisiopatologia Respiratoria-ASST Spedali Civili di Brescia, Brescia, Italy.
  • Caminati A; U.O. Pneumologia e Fisiopatologia Respiratoria-ASST Spedali Civili di Brescia, Brescia, Italy.
  • Intotero M; Department of Medical Sciences, San Giuseppe Hospital, MultiMedica IRCCS, Milan, Italy.
  • Sergio P; Department of Clinical Sciences and Community Health, Università degli Studi di Milano, Milan, Italy.
  • Monzillo G; U.O. di Pneumologia e Terapia Semi-Intensiva Respiratoria, Servizio di Fisiopatologia Respiratoria ed Emodinamica Polmonare. Ospedale San Giuseppe-MultiMedica IRCCS, via San Vittore 12, 20123, Milan, MI, Italy.
  • Leati G; U.O.C. Radiologia, Civile Hospital, Vimercate, MB, Italy.
  • Borghesi A; U.O. Radiodiagnostica, Cremona Hospital, ASST Cremona, Cremona, Italy.
  • Zompatori M; U.O.C. Radiodiagnostica, Ospedale G. Salvini, ASST-Rhodense, Garbagnate Milanese, MI, Italy.
  • Corso R; U.O.C. Radiologia, Ospedale Maggiore, Crema, Italy.
  • Valsecchi MG; U.O. Radiologia, ASST Spedali Civili di Brescia, Brescia, Italy.
  • Bellani G; Dipartimento di Radiologia, Policlinico di Sant'Orsola, Alma Mater Studiorum-Università di Bologna, Bologna, Italy.
  • Foti G; Radiology Unit, Gerardo Hospital, ASST Monza, Monza, Italy.
  • Pesci A; Bicocca Bioinformatics Biostatistics and Bioimaging B4 Center, University of Milano Bicocca, Monza, Italy.
Respir Res ; 23(1): 65, 2022 Mar 21.
Article en En | MEDLINE | ID: mdl-35313890
ABSTRACT

BACKGROUND:

Long-term pulmonary sequelae following hospitalization for SARS-CoV-2 pneumonia is largely unclear. The aim of this study was to identify and characterise pulmonary sequelae caused by SARS-CoV-2 pneumonia at 12-month from discharge.

METHODS:

In this multicentre, prospective, observational study, patients hospitalised for SARS-CoV-2 pneumonia and without prior diagnosis of structural lung diseases were stratified by maximum ventilatory support ("oxygen only", "continuous positive airway pressure (CPAP)" and "invasive mechanical ventilation (IMV)") and followed up at 12 months from discharge. Pulmonary function tests and diffusion capacity for carbon monoxide (DLCO), 6 min walking test, high resolution CT (HRCT) scan, and modified Medical Research Council (mMRC) dyspnea scale were collected.

RESULTS:

Out of 287 patients hospitalized with SARS-CoV-2 pneumonia and followed up at 1 year, DLCO impairment, mainly of mild entity and improved with respect to the 6-month follow-up, was observed more frequently in the "oxygen only" and "IMV" group (53% and 49% of patients, respectively), compared to 29% in the "CPAP" group. Abnormalities at chest HRCT were found in 46%, 65% and 80% of cases in the "oxygen only", "CPAP" and "IMV" group, respectively. Non-fibrotic interstitial lung abnormalities, in particular reticulations and ground-glass attenuation, were the main finding, while honeycombing was found only in 1% of cases. Older patients and those requiring IMV were at higher risk of developing radiological pulmonary sequelae. Dyspnea evaluated through mMRC scale was reported by 35% of patients with no differences between groups, compared to 29% at 6-month follow-up.

CONCLUSION:

DLCO alteration and non-fibrotic interstitial lung abnormalities are common after 1 year from hospitalization due to SARS-CoV-2 pneumonia, particularly in older patients requiring higher ventilatory support. Studies with longer follow-ups are needed.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: COVID-19 / Enfermedades Pulmonares Tipo de estudio: Clinical_trials / Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Respir Res Año: 2022 Tipo del documento: Article País de afiliación: Italia

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: COVID-19 / Enfermedades Pulmonares Tipo de estudio: Clinical_trials / Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Respir Res Año: 2022 Tipo del documento: Article País de afiliación: Italia